FluidAI's artificial intelligence-powered postsurgical monitor, Stream™ Platform, launches globally

Canadian medical technology company, FluidAI Medical (FluidAI), is set to revolutionize postoperative care with the launch of its ground-breaking medical device, the Stream™ Platform in Canada and Saudi Arabia.

Introduction to Stream™ Platform, by FluidAI

Through the use of the Stream™ Platform, surgeons have the potential to make a more accurate and timely diagnosis of postoperative leaks, dreaded complications of digestive tract surgeries, which can lead to better treatment outcomes and an improved quality of life for their patients. Stream™ Platform's international debut, made possible through the company's strategic partnerships with Canadian Hospital Specialties Limited (CHS Ltd.) and Gulf Medical Co. Ltd., marks an exciting new chapter in postoperative care around the world.

Surgeons reacting to Stream™ Platform and the Origin™ device by FluidAI

"The launch of Stream™ Platform is a pivotal milestone in addressing the critical need we hear from surgeons across the globe: patients suffer from life-threatening complications, and we don't catch them soon enough. With a data-driven approach backed by artificial intelligence, we can predict complications and enable preventative medicine - an entirely new paradigm of care that is precise and tailored to individual patient needs."

- Youssef Helwa, CEO and Cofounder of FluidAI